期刊文献+

肝细胞肝癌中微血管密度及MMP-2和MMP-9的表达与术后转移及预后的关系 被引量:7

The Microvessel Density and Expression of MMP-2 and MMP-9 in Hepatocellular Carcinoma and Their Correlation with Metastasis and Prognosis
暂未订购
导出
摘要 目的:探讨微血管密度(MVD)、基质金属蛋白酶-2(MMP-2)和MMP-9在肝细胞肝癌转移中的作用及其各自和预后的相关性。方法:以石蜡包埋组织切片,免疫组化SP法染色分别检测97例肝细胞肝癌MVD和MMP-2、MMP-9表达的情况,其中复发与转移组49例,非复发与转移组48例。结果:转移组MVD高于无转移组(P=0.015),转移组MMP-2和MMP-9表达高于无发转移组(P=0.009,P=0.043),差异具有统计学意义。结论:MVD增高、MMP-2和MMP-9过度表达可能与肝细胞肝癌转移、不良生存预后存在相关性。 Objective: To investigate the effect of microvessel density and expression of MMP-2 and MMP-9 on the metastasis of hepatocellular carcinoma and their correlation with patients' prognosis. Methods: Immunohistochemistry (SP) was employed to detect MVD and expression of MMP-2 and MMP-9 in 97 samples of hepatocellular carcinoma. There were 49 cases with metastasis and 48 cases with no metastasis. Results: The abnormal MVD and expression of MMP-2 and MMP-9 in cases with metastasis were higher than those in cases with no metastasis (P=0.015; P=0.009). Conclusion: Abnomal MVD and expression of MMP-2 and MMP-9 may play an important role in the metastasis of hepatocellular carcinoma and indicate poor prognosis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第7期385-387,共3页 Chinese Journal of Clinical Oncology
基金 天津市应用基础及前沿技术研究计划重点项目(编号:08JCZDJC23500) 天津市应用基础及前沿技术研究计划面上项目(编号:09JCYBJC12100) 天津市科技支撑项目(中瑞国际合作)资助(编号:09ZCZDSF04400)~~
关键词 MVD MMP-2 MMP-9 转移 MVD MMP-2 MMP-9 Metastasis
  • 相关文献

参考文献9

  • 1Tung-Ping Poon RT,Fan ST,Wong J.Risk factors,prevention and management of postoperative recurrence after resection of hepato-cellular carcinoma[J].Ann Surg,2000,232(1):10-24.
  • 2Folkman J.Tumor angiogensis:role in regulation of tumor growth[J].Symp Soc Dev Biol,1974,30(0):43-52.
  • 3Folkman J.Tumor angiogenesis:therapeutic implications[J].N Engl J Med,1971,285(21):1182-1186.
  • 4Volm M,Mattern J.Koomagi R.Angiostatin expression in non-small cell lung cancer[J].Clin Cancer Res,2000,6(8):3236-3240.
  • 5el-Assal ON,Yamanoi A,SodaY,et al.Nagasue N.Proposal of in-vasiveness score to predict recurence and survival after curative he-patic resection for hepatocellular carcinoma[J].Surgery,1997,122(3):571-577.
  • 6Zhang S,ZHang D,Sun B.Vasculogenic mimicry:current status and future prospects[J].Cancer Lett,2007,254(2):157-164.
  • 7Sun B,Zhang S,Zhang D,et al.The influence of different microen-vironments on melanoma invasiveness and microcirculation patterns:an animal experiment study in the mouse model[J].J Cancer Res Clin Oncol,2007,133(12):979-985.
  • 8Sun B,Zhang S,Zhang D,et al.Vasculogenic mimicry is associated with high tumor grade,invasion and metastasis,and short survival in patients with hepatocellular carcinoma[J].Oncol Rep,2006,16(4):693-698.
  • 9Roy R,Yang J.Moses MA.Matrix metalloproteinases as novel bio-markers and potential therapeutic targets in human dancer[J].J Clin Oncol,2009,27(31):5287-5297.

同被引文献52

  • 1鲁照明,刘红涛,许培荣,侯桂琴,薛乐勋.Notch1信号途径在食管鳞癌细胞株EC9706的作用研究[J].中国肿瘤临床,2007,34(13):740-743. 被引量:11
  • 2Boddicker R L, Whitley E M, Davis J E, et al.Low-dose dietary resveratrol has differential effects on colorectal tumorigenesis in adiponectin knockout and wild-type mice[J].Nutr Cancer, 2011, 63(8):1328-1338.
  • 3Huang X, Zhu H L.Resveratrol and its analogues:promising antitumor agents [J].Anticancer Agents Med Chem, 2011, 11(5):479-490.
  • 4Yu H B, Zhang H F, Zhang X, et al.Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF- kappa B-mediated mechanism[J].Hepatogastroenterology, 2010, 57(102):1241-1246.
  • 5Kuo P L, Chiang L C, Lin C C.Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells[J].Life Sci, 2002, 72(1):23-34.
  • 6Boddieker RL, Whitley EM, Davis JE, et al. Low-dose dietary resvera- trol has differential effects on colorectal tumorigenesis in adiponecfinknockout and wild-type mice [ J ]. Nutr Cancer, 2011,63 ( 8 ) : 1328- 1338.
  • 7Huang X, Zhu HL Resveratrol and its analogues:promising antitumor agents[J]. Anticancer Agents Med Chem,2011,11 (5) :479-490.
  • 8Yu HB, Zhang HF, Zhang X, et 81. Resveratrol inhibits VEGF expres- sion of human hepatocellular carcinoma cells through a NF-kappa B- mediated mechanism [ J ] . Hepatogastroenterology, 2010, 57 ( 102- 103) :1241-6.
  • 9Kuo PL, Chiang LC, Lin CC. Resveratml-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells [J]. Life Sci, 2002,72 ( 1 ) :23-34.
  • 10Yu H,Pan C,Zhao Set aL Resveratrol inhibits tumor necrosis factor- alpha-mediated matrix met allopmteinase-9 expression and invasion of human hepatocellular carcinoma cells [ J]. Biomed Pharrnacother, 2008,62(6) :366-72.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部